Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-06

Ryan K Dare

Role not yet determined Is this you? Add your title

Also affiliated: Centers for Disease Control and Prevention (2007–2010); SIU Medicine (2024); University of Arkansas Medical Center (2020–2025); Central Arkansas Veterans Healthcare System (2023); Ministry of Health (2010); University of Pittsburgh Medical Center (2007–2008); Association Clinique et Thérapeutique Infantile du Val de Marne (2023–2024); Vanderbilt University Medical Center (2016)

17 h-index 65 pubs 1,785 cited

  • Humans
  • Male
  • Adult
  • Female
  • Anti-Bacterial Agents
  • COVID-19
  • Middle Aged
  • Retrospective Studies
  • SARS-CoV-2
  • Reverse Transcriptase Polymerase Chain Reaction
  • Respiratory Tract Infections
  • Bacteremia
  • Antimicrobial Stewardship
  • Aged
  • Adolescent

Biography and Research Information

OverviewAI-generated summary

Ryan K Dare's research focuses on the identification and diagnosis of viral and bacterial infections, particularly those affecting the respiratory tract. His work has involved the development and application of molecular diagnostic techniques, such as real-time reverse-transcription polymerase chain reaction (RT-PCR) assays, for comprehensive pathogen detection. Dare has investigated human coronavirus infections in Thailand, rhinoviruses, respiratory syncytial virus (RSV) burden in hospitalized patients, and the simultaneous identification of multiple RNA viruses causing respiratory tract infections. He has also explored infections such as Rickettsia felis and human metapneumovirus, including in specific patient populations like immunosuppressed lung transplant recipients and children evaluated for pertussis.

More recently, Dare's research has extended to clinical studies of COVID-19, including investigations into treatment options for hospitalized patients with COVID-19 pneumonia. He also examines drug-associated myopathy, specifically the effect of statin coadministration on daptomycin-associated myopathy. His scholarship includes 66 publications with over 1,700 citations and an h-index of 17. Key collaborators at the University of Arkansas for Medical Sciences include Juan Carlos Rico Crescencio, Brett Bailey, Jacob T. Painter, and Jacob M. Keck.

Metrics

  • h-index: 17
  • Publications: 65
  • Citations: 1,785

Selected Publications

  • Real-time Nanopore de novo assembly of ESKAPE pathogens: Implications for antibiotic stewardship (2026)
  • Amplifying Our Voices: Fostering Advocacy in Infectious Diseases Fellowship (2025)
    Open Forum Infectious Diseases DOI OpenAlex
  • Use of Aztreonam–Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing Enterobacter cloacae (2025)
    Antibiotics 2 citations DOI OpenAlex
  • Evaluation of Antibiotic Selection in the Emergency Department Following the Implementation of an Infectious Source-Specific Order Set (2025)
    Journal of Pharmacy Practice 1 citation DOI OpenAlex
  • Measurement of Practice-Level Antibiotic Utilization in a Medicaid Patient-Centered Medical Home Program (2025)
    The Annals of Family Medicine 1 citation DOI OpenAlex
  • Device Evaluation, Treatment, and Explantation Recommendations (DETER): Review and Best Practices for Managing Neuromodulation Device Infections (2025)
    Journal of Pain Research 4 citations DOI OpenAlex
  • It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis (2025)
    Infectious Diseases and Therapy 10 citations DOI OpenAlex
  • P-842. Community-onset vs. Hospital-onset Staphylococcus aureus Bacteremia: Implications for Patients and Healthcare Systems (2025)
    Open Forum Infectious Diseases DOI OpenAlex
  • Dalbavancin Use in Bone and Joint Infections (2024)
    Arthroplasty Today 3 citations DOI OpenAlex
  • Diagnostic utility of nasal methicillin-resistant Staphylococcus aureus polymerase chain reaction testing in head and neck infection (2024)
    Antimicrobial Stewardship & Healthcare Epidemiology DOI OpenAlex
  • Treatment-emergent cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii is associated with insertion sequence IS Aba36 in the siderophore receptor pirA (2024)
    Antimicrobial Agents and Chemotherapy 25 citations DOI OpenAlex
  • Fractal Changes of the Retinal Microvasculature in Syphilitic Uveitis (2024)
    Ocular Immunology and Inflammation 2 citations DOI OpenAlex
  • A Tale of Mummified Eggs in Urine of a US Veteran (2024)
    Infectious Diseases in Clinical Practice DOI OpenAlex
  • 159. Diagnostic Utility of Nasal Methicillin-resistant Staphylococcus aureus Polymerase Chain Reaction Testing in Head and Neck Infection (2023)
    Open Forum Infectious Diseases DOI OpenAlex
  • 2902. Dalbavancin Use in Bone and Joint Infections (2023)
    Open Forum Infectious Diseases 1 citation DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

As listed on this researcher's institutional profile.

  • Healthcare Facility Reporting of Antibiotic Use/Antibiotic Resistance Data Incentive Project Centers for Disease Control & Prevention via Arkansas Department of Health & Human Services
  • Real-Time High Resolution Method for Genomic
  • Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-1 IM) NIH
  • 24360 (IRB 261851) CTSA (Subaward) - Randomized Master Protocol for Immune Modulators for Treating COVID-19 DHHS - Biomedical Advanced Research and Development Authority via Duke University

Collaboration Network

216 Collaborators 93 Institutions 4 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics